Fentanyl 12 Mcg Transdermal Patch For Postoperative Pain

The investigators designed a prospective randomized study to investigate the effect of fentanyl 12 mcg transdermal patch on postoperative pain following unilateral, single-level laminectomy/discectomy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

20 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients between the ages of 20-70 years
ASA physical status 1-2 patients undergoing single-level laminectomy/discectomy

Exclusion criteria

A history of allergy to any study drugs
History of opioid use, obstructive sleep apnea
Any psychological disorders
hepatic or renal failure

Treatment and study plan

Fentanyl transdermal patch

Drug

Patients received fentanyl 12 mcg transdermal patch group 8 hours preoperatively and until 24 hours after the surgery

Primary outcomes

Numeric rating score for pain (NRS)

Time frame: Postoperative 24 hours

Sponsors and collaborators

Lead sponsor

Baskent University

Other

Registry information

Official study title

The Effect Of Fentanyl 12 Mcg Transdermal Patch On Postoperative Pain Following Unilateral, Single-Level Laminectomy/Discectomy: A Randomized, Controlled, Double-Blind Study

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Jun 26, 2017
Registry last updated: Jun 26, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed